buyWeak
Benjamin R Yerxa bought $10k of CLSD
director at Clearside Biomedical, Inc.. 7,813 shares at an average of $1.31, traded May 15, 2024, filed May 15, 2024.
Conviction score
25Value
$10k
7,813 shares
Holdings after
17,957
+77% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- 0Trade size$10k at market
- +10Relative to holdingsHoldings up 77%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-013248, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 15, 2024 | POpen-market purchase Common Stock | +7,813 | $1.31 | $10k | 17,957 | May 15, 2024 |
Related signals
Other insiders at Clearside Biomedical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | CLSDbuy Clearside Biomedical, Inc. | Clay Thorp director | $14k 15,000 shares | +9% | |
| 31Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong Chief Medical Officer | $37k 36,500 shares | +57% | |
| 25Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong Chief Medical Officer | $25k 23,500 shares | +59% | |
| 34Weak | CLSDbuy Clearside Biomedical, Inc. | Anthony S Gibney director | $130k 100,000 shares | - | |
| 30Weak | CLSDbuy Clearside Biomedical, Inc. | Ngai Hang Victor Chong CHIEF MEDICAL OFFICER | $48k 30,000 shares | - | |
| 24Weak | CLSDbuy Clearside Biomedical, Inc. | Bradford T Whitmore owner | $600k 444,444 shares | +11% | |
| 30Weak | Clearside Biomedical, Inc. | Charles A. Deignan Chief Financial Officer | $17k 12,900 shares | -3% | |
| 33Weak | Clearside Biomedical, Inc. | George M Lasezkay CEO | $23k 18,000 shares | -4% | |
| 12Weak | CLSDbuy Clearside Biomedical, Inc. | Bradford T Whitmore owner | $100k 135,778 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.